The U.S. Pharmaceutical Industry: Why Major Growth in Times of Cost Containment?

Author(s)
Berndt, Ernst R.
Keywords
Containment
Industry
Pharmaceutical Industry
Drugs and Drug Industry
Business Ethics
Economics of Health Care

Full record
Show full item record
URI
http://hdl.handle.net/20.500.12424/332720
Online Access
http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=The+U.S.+Pharmaceutical+Industry:+Why+Major+Growth+in+Times+of+Cost+Containment?&title=Health+Affairs+&volume=20&issue=2&spage=100-114&date=2001-03&au=Berndt,+Ernst+R.
https://dx.doi.org/10.1377/hlthaff.20.2.100
http://hdl.handle.net/10822/944554
Date
2016-01-08
Identifier
oai:repository.library.georgetown.edu:10822/944554
doi:10.1377/hlthaff.20.2.100
Health Affairs 2001 March-April; 20(2): 100-114
http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=The+U.S.+Pharmaceutical+Industry:+Why+Major+Growth+in+Times+of+Cost+Containment?&title=Health+Affairs+&volume=20&issue=2&spage=100-114&date=2001-03&au=Berndt,+Ernst+R.
http://dx.doi.org/10.1377/hlthaff.20.2.100
http://hdl.handle.net/10822/944554
DOI
10.1377/hlthaff.20.2.100
Collections